Berfin Temelli, MD, is a Nuclear Medicine Specialist in the Department of Nuclear Medicine at Mersin City Education and Research Hospital, Mersin, Türkiye. She received her MD degree from Çukurova University Faculty of Medicine in 2007 and completed her residency in Nuclear Medicine at Hacettepe University, Ankara (2008–2012). After completing her compulsory public service at Fırat University (2012–2014), she has worked in Mersin since 2014. Her clinical practice covers oncologic PET/CT (including PSMA and DOTATATE PET/CT), myocardial viability imaging, PET/CT in infective endocarditis, cardiac nuclear imaging, and radionuclide therapies. Her research focuses on quantitative PET/CT imaging, SUV normalization, physiological FDG uptake patterns, and diagnostic performance assessment. She is a member of the European Association of Nuclear Medicine and the Turkish Society of Nuclear Medicine, and serves on the Mersin Provincial Radiological and Nuclear Emergencies Advisory Commission. In September 2026, she completed the International Medical Management of Radiation Injuries (I-MED) Course conducted by the U.S. DOE/NNSA and REAC/TS in Ankara, Türkiye.
Berfin Temelli, MD, is a Nuclear Medicine Specialist in the Department of Nuclear Medicine at Mersin City Education and Research Hospital, Mersin, Türkiye. She received her MD degree from Çukurova University Faculty of Medicine in 2007 and completed her residency in Nuclear Medicine at Hacettepe University, Ankara (2008–2012). After completing her compulsory public service at Fırat University (2012–2014), she has worked in Mersin since 2014. Her clinical practice covers oncologic PET/CT (including PSMA and DOTATATE PET/CT), myocardial viability imaging, PET/CT in infective endocarditis, cardiac nuclear imaging, and radionuclide therapies. Her research focuses on quantitative PET/CT imaging, SUV normalization, physiological FDG uptake patterns, and diagnostic performance assessment. She is a member of the European Association of Nuclear Medicine and the Turkish Society of Nuclear Medicine, and serves on the Mersin Provincial Radiological and Nuclear Emergencies Advisory Commission. In September 2026, she completed the International Medical Management of Radiation Injuries (I-MED) Course conducted by the U.S. DOE/NNSA and REAC/TS in Ankara, Türkiye.